They uptake antigens from necrotic tumor cells, transport them to draining lymph nodes, and cross-present soluble and particulate antigens via MHC class I molecules (MHC-I) to cancer-specific CD8+ T cells, stimulating tumor-specific CTL responses (23). This evidence concerns the gene CD8A and cancer.